Q32 Bio Inc.
QTTB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$0 | $0 | $0 | $0 |
| Revenue | $0 | -$0 | $0 | $0 |
| % Growth | 100% | -200% | -80.4% | – |
| Gross Profit | -$0 | -$0 | $0 | $0 |
| % Margin | – | 100% | 100% | 71.9% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | 718% | -584.2% | -253.8% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | 808% | -643.6% | -281.9% |
| EPS Diluted | -6.58 | -16.7 | -13.42 | -12.23 |
| % Growth | 60.6% | -24.4% | -9.7% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |